Persistence of Antidepressant Treatment Effects in a Pharmacotherapy Plus Psychotherapy Trial for Active Injection Drug Users

REFERENCES

• Croughan JL, Miller JP, Wagelin D, Whitman BY. Psychiatric illness in male and female narcotic addicts. J Clin Psychiatry. 1982;43:225–228. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry. 1982;39:151–156. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brienza RS, Stein MD, Chen MH, , et al. Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat. 2000;18:331–337. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Kosten TR, Weisman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Arch Gen Psychiatry. 1986;43:739–745. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carroll KM, Power MED, Bryant K. One-year follow-up status of treatment-seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome. J Nerv Men Dis. 1993;181:71–79. [CSA]
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatment: role of psychiatric severity. Arch Gen Psychiatry. 1983;40:620–625. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Woody GE, Luborsky L, McLellan T, , et al. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry. 1983;40:639–645. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and HIV injection risk behaviors. Am J Psychiatry. 2003;160:1659–1662. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Marlatt GA, Gordon JR. Relapse Prevention. New York: Guilford Press; 1985.
   Google Scholar
• Solomon DA, Keller MB, Leon AC, , et al. Recovery from major depression—a 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry. 1997;54:1001–1006. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nunes EV, Goehl L, Seracini A, , et al. A modification of the structured clinical interview for DSM-III-R to evaluate methadone patients. Am J Addict. 1996;5:241–248. [CSA]
   Web of Science ®Google Scholar
• Hasin D, Trautman K, Endicott J. Psychiatric research interviews for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol and drugs. Psychopharmacol Bull. 1998;34:3–8. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between “substance-induced” and “independent” depression and anxiety disorders. Am J Addict. 1995;4:107–117. [CSA]
   Web of Science ®Google Scholar
• Kranzler HR, Kadden RM, Babor TF, Tennen H, Rounsaville BJ. Validity of the SCID in substance abuse patients. Addiction. 1996;91:859–866. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stein MD, Solomon DA, Herman DS, , et al. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatry. 2004;61:152–159. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Williams J, Gibbons M. Structured Clinical Interview for DSM-IV, Patient Version. New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
   Google Scholar
• Miller IW, Bishop S, Norman WH, Maddever H. The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res. 1985;14:131–142. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brown RA, Evans DM, Miller IW, Burgess ES, Mueller TI. Cognitive-behavioral treatment for depression in alcoholics. J Consult Clin Psychol. 1997;65:715–726. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lewinsohn PM, Graf M. Pleasant activities and depression. J Consult Clin Psychol. 1973;41:261–268. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fawcett J, Epstein P, Fiester S, Elkin I, Autry J. Clinical management—imipramine/placebo administration manual: NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987;23:309–324. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, , et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treatment. 1992;9:199–213. [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Dufour H, Brion S. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry. 1988;9:69–76. [CSA]
   Google Scholar
• Keller M, McCullough J, Klein D, , et al. The acute treatment of chronic major depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. N Engl J Med. 2000;342:1462–1470. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miller IW, Keitner GI. Combined medication and psychotherapy in the treatment of chronic mood disorders. Psychiatr Clin North Am. 1996;19:151–171. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nelson JC. Overcoming treatment resistance in depression. J Clin Psychiatry. 1998;59:13–19. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hirschfeld RMA, Montgomery SA, Aguglia E, , et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry. 2002;63:826–837. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kleber HD, Weissman MM, Rounsaville BA, Wilber CH, Prusoff BA, Riordan CE. Imipramine as treatment for depression in addicts. Arch Gen Psychiatry. 1983;40:649–653. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Woody GE, O'Brien CP, Rickels K. Depression and anxiety in heroin addicts: a placebo controlled study of doxepin in combination with methadone. Am J Psychiatry. 1975;132:447–450. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Woody GE, O'Brien CP, McClellan AT, Marcovici M, Evans BD. The use of antidepressants with methadone in depression methadone maintenance patients. Ann N Y Acad Sci. 1982;12:120–127. [CSA]
   Google Scholar
• Titievsky J, Seco G, Barranco M, Kyle EM. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double blind study. J Clin Psychiatry. 1982;43:454–456. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nunes EV, Quitkin FM, Donovan SJ, , et al. Imipramine treatment of opiate-dependent patients with depressive disorders: a placebo-controlled trial. Arch Gen Psychiatry. 1998;55:153–160. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Steer RA, Kotzker E. Affective changes in male and female methadone patients. Drug Alcohol Depend. 1980;5:115–122. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Posternak MA, Miller I. Untreated short-term course of major depression: a meta-analysis of outcomes from studies using wait-list control groups. J Affect Disord. 2001;66:139–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Desmond DP, Maddux JF, Johnson TH, Confer BA. Obtaining follow-up interviews for treatment evaluation. J Subst Abuse Treat. 1995;12:95–102. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stein MD, Charuvastra A, Maksad J, Anderson BJ. A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE). Addiction. 2002;97:691–700. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Primm AB, Gomez MB, Tzolova-Iontchev I, Perry W, Vu HT, Crum RM. Mental health versus substance abuse treatment programs for dually diagnosed patients. J Subst Abuse Treat. 2000;19:285–290. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar